222 related articles for article (PubMed ID: 37578562)
1. Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach.
Arokia Rajan MS; Thirunavukkarasu R; Joseph J; Palliyath GK; Somarathinam K; Kothandan G; Subaramaniyan K; Ullah R; Rajesh RP
Curr Microbiol; 2023 Aug; 80(10):318. PubMed ID: 37578562
[TBL] [Abstract][Full Text] [Related]
2. Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications.
Cunha L; Grenha A
Mar Drugs; 2016 Feb; 14(3):. PubMed ID: 26927134
[TBL] [Abstract][Full Text] [Related]
3. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
[TBL] [Abstract][Full Text] [Related]
4. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
[TBL] [Abstract][Full Text] [Related]
5. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
Uddin R; Zahra NU; Azam SS
Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
[TBL] [Abstract][Full Text] [Related]
6. Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase in
Chanda A; Kalita S; Mishra AK; Changkakoti L; Sarma JB; Biswas K; Kakati D; Mohanta YK; Tanti B; Mahanta S; Saravanan M
Biomed Res Int; 2022; 2022():4661491. PubMed ID: 36225979
[TBL] [Abstract][Full Text] [Related]
7. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
8. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing.
Dwivedi M; Mukhopadhyay S; Yadav S; Dubey KD
Comput Biol Med; 2022 Jul; 146():105607. PubMed ID: 35617724
[TBL] [Abstract][Full Text] [Related]
9. Lead identification against
Hassam M; Khan K; Jalal K; Tariq M; Tarique Moin S; Uddin R
J Biomol Struct Dyn; 2023 Sep; ():1-18. PubMed ID: 37747063
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
Kumari M; Subbarao N
J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
[TBL] [Abstract][Full Text] [Related]
11. Disruption of redox catalytic functions of peroxiredoxin-thioredoxin complex in Mycobacterium tuberculosis H37Rv using small interface binding molecules.
Gurung AB; Das AK; Bhattacharjee A
Comput Biol Chem; 2017 Apr; 67():69-83. PubMed ID: 28063347
[TBL] [Abstract][Full Text] [Related]
12. Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study.
Rabaan AA; Halwani MA; Garout M; Turkistani SA; Alsubki RA; Alawfi A; Alshengeti A; Najim MA; Al Kaabi NA; Alqazih TQ; Aseeri AA; Bahitham AS; Alsubaie MA; Alissa M; Aljeldah M
Mol Divers; 2023 Aug; ():. PubMed ID: 37578620
[TBL] [Abstract][Full Text] [Related]
13. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
Nowosielski M; Hoffmann M; Kuron A; Korycka-Machala M; Dziadek J
J Comput Chem; 2013 Apr; 34(9):750-6. PubMed ID: 23233437
[TBL] [Abstract][Full Text] [Related]
14. High throughput screening against pantothenate synthetase identifies amide inhibitors against
Pradhan S; Sinha C
In Silico Pharmacol; 2018; 6(1):9. PubMed ID: 30607322
[TBL] [Abstract][Full Text] [Related]
15. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Effects of Ligand Binding on Leucyl-tRNA Synthetase Inhibitors for Tuberculosis: In Silico Analysis and Isothermal Titration Calorimetry Validation.
Rehman ZU; Najmi A; Zoghebi K
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927114
[TBL] [Abstract][Full Text] [Related]
17. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
18. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
19. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
20. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
